Brand Name
| Therapeutic Class
| Dose/Strength | Status | Notes & Restrictions |
Carbidopa-Levodopa Oral Tablet 10-100 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 10-100 mg | | |
Carbidopa-Levodopa Oral Tablet 25-100 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 25-100 mg | | |
Carbidopa-Levodopa Oral Tablet 25-250 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 25-250 mg | | |
Carbidopa-Levodopa Oral Tablet Extended Release 25-100 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet Extended Release 25-100 mg | | |
Carbidopa-Levodopa Oral Tablet Extended Release 50-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet Extended Release 50-200 mg | | |
Carbidopa-Levodopa Oral Tablet,Disintegrating 10-100 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet,Disintegrating 10-100 mg | | |
Carbidopa-Levodopa Oral Tablet,Disintegrating 25-100 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet,Disintegrating 25-100 mg | | |
Carbidopa-Levodopa Oral Tablet,Disintegrating 25-250 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet,Disintegrating 25-250 mg | | |
Carbidopa-Levodopa-Entacapone Oral Tablet 12.5-50-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 12.5-50-200 mg | | |
Carbidopa-Levodopa-Entacapone Oral Tablet 18.75-75-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 18.75-75-200 mg | | |
Carbidopa-Levodopa-Entacapone Oral Tablet 25-100-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 25-100-200 mg | | |
Carbidopa-Levodopa-Entacapone Oral Tablet 31.25-125-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 31.25-125-200 mg | | |
Carbidopa-Levodopa-Entacapone Oral Tablet 37.5-150-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 37.5-150-200 mg | | |
Carbidopa-Levodopa-Entacapone Oral Tablet 50-200-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 50-200-200 mg | | |
Duopa J-Tube Intestinal Pump Suspension 4.63-20 Mg/Ml Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Intestinal Pump Suspension 4.63-20 mg/mL | | |
Inbrija Inhalation Capsule 42 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Capsule 42 mg | | |
Inbrija Inhalation Capsule, W/Inhalation Device 42 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Capsule, W/Inhalation Device 42 mg | | |
Rytary Oral Capsule, Extended Release 23.75-95 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Capsule, Extended Release 23.75-95 mg | | |
Rytary Oral Capsule, Extended Release 36.25-145 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Capsule, Extended Release 36.25-145 mg | | |
Rytary Oral Capsule, Extended Release 48.75-195 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Capsule, Extended Release 48.75-195 mg | | |
Rytary Oral Capsule, Extended Release 61.25-245 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Capsule, Extended Release 61.25-245 mg | | |
Sinemet Oral Tablet 10-100 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 10-100 mg | | |
Sinemet Oral Tablet 25-100 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 25-100 mg | | |
Sinemet Oral Tablet 25-250 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 25-250 mg | | |
Stalevo 100 Oral Tablet 25-100-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 25-100-200 mg | | |
Stalevo 125 Oral Tablet 31.25-125-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 31.25-125-200 mg | | |
Stalevo 150 Oral Tablet 37.5-150-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 37.5-150-200 mg | | |
Stalevo 200 Oral Tablet 50-200-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 50-200-200 mg | | |
Stalevo 50 Oral Tablet 12.5-50-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 12.5-50-200 mg | | |
Stalevo 75 Oral Tablet 18.75-75-200 Mg Central Nervous System Agents Dopamine Precursors | Central Nervous System Agents Dopamine Precursors | Tablet 18.75-75-200 mg | | |
Icon | Restriction | Definition |
| ACA Preventive Drug | The Affordable Care Act (ACA) makes certain preventive medications available to you at no cost. Coverage of any medication flagged as “ACA PV” (including certain over-the-counter (OTC) medications) requires a prescription from a licensed health care provider. For additional details on coverage for these medications, please click on the "Coverage Note" icon next to the drug name. |
| Coverage Note | Coverage restrictions based on age, gender, or condition may apply to this medication. Click on the "Coverage Note" icon for additional details. |
| NonPreferred | This drug has a preferred drug option. You can find preferred options to non-preferred drugs by clicking on the therapeutic class above and selecting the appropriate subclass. Preferred drug options are listed without the NP flag. Talk to your provider to see if one of these options is right for you. |
| Oral Chemo Drug | Oral
Chemotherapy Drug. If you are employed by a Washington, Oregon or Alaska-based
group (effective 1/1/17 for Alaskan groups) OR purchasing Individual coverage
(non-employer based) in Washington, Oregon or Alaska (Alaska as of 1/1/17) ,
certain oral chemotherapy drugs may be covered under your medical plan. Please
check your member booklet or call the customer service number on the back of
your member ID card to verify your benefits. |
| Prior Authorization | You (or your doctor) are required to get prior authorization from our plan before you fill your prescription for this drug. Without prior approval, we may not cover this drug. You can click on the "PA" icon next to the drug to see the coverage criteria. For information on how to request prior authorization, please see the “Drugs Requiring Approval” section on our website. |
| Quantity Limit | Our plan limits the amount of this drug that is covered per prescription, or within a specific time frame. You can click on the "QL" icon next to the drug to see this limit. If you need an exception to this quantity limit, your doctor or pharmacist should call 1-888-261-1756. |
| Specialty Pharmacy | Specialty drugs are typically self-injected and
are often used to treat complex medical conditions. These drugs may require
more involvement with your physician, and may require special storage and
handling. |